Sleep Aids (Pharmacies) - Switzerland

  • Switzerland
  • Revenue in the Sleep Aids market is projected to reach US$32.59m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.46%, resulting in a market volume of US$35.04m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.68 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Switzerland has been experiencing steady growth in recent years. Customer preferences for sleep aids have shifted towards natural and herbal remedies, driving the demand for these products. Additionally, the increasing prevalence of sleep disorders and the growing awareness about the importance of quality sleep have contributed to the market's development.

Customer preferences:
In Switzerland, customers are increasingly seeking natural and herbal sleep aids as they are perceived to have fewer side effects compared to pharmaceutical alternatives. This preference for natural remedies aligns with global trends, where consumers are becoming more conscious of their health and are opting for products with fewer synthetic ingredients. As a result, the demand for herbal sleep aids has been on the rise, with customers looking for products containing ingredients like chamomile, valerian root, and lavender.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in Switzerland is the increasing prevalence of sleep disorders. Factors such as stress, busy lifestyles, and digital dependency have contributed to the rise in sleep disorders among the population. As a result, there is a growing demand for sleep aids to help individuals improve the quality and duration of their sleep. This trend is expected to continue driving the growth of the market in the coming years. Another trend in the market is the growing awareness about the importance of quality sleep. People are becoming more educated about the negative effects of sleep deprivation on their overall health and well-being. This awareness has led to an increased focus on sleep hygiene and the use of sleep aids to address sleep-related issues. As a result, there is a greater willingness among individuals to seek professional advice and explore different sleep aid options available in pharmacies.

Local special circumstances:
Switzerland has a strong healthcare system and a high standard of living, which has contributed to the growth of the Sleep Aids (Pharmacies) market. The country has a well-established network of pharmacies that offer a wide range of sleep aids to cater to the diverse needs of the population. Additionally, the Swiss population is known for its health-consciousness, which further drives the demand for sleep aids and other wellness products.

Underlying macroeconomic factors:
The Sleep Aids (Pharmacies) market in Switzerland is also influenced by underlying macroeconomic factors. The country has a stable economy and a high disposable income per capita, which allows individuals to afford sleep aids and prioritize their sleep health. Furthermore, the aging population in Switzerland has contributed to the growth of the market, as older individuals are more likely to experience sleep-related issues and seek sleep aids to improve their sleep quality. In conclusion, the Sleep Aids (Pharmacies) market in Switzerland is developing due to changing customer preferences, including a shift towards natural and herbal sleep aids. The increasing prevalence of sleep disorders and the growing awareness about the importance of quality sleep have also contributed to the market's growth. Switzerland's strong healthcare system, high standard of living, and health-conscious population further support the development of the market. The stable economy and high disposable income per capita in the country also play a role in driving the demand for sleep aids.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)